Table 1. Baseline Patient Characteristic of the 88 patients with serum CYFRA levels analyzed.
| Characteristics | CYFRA decrease =<27% (N=47) |
CYFRA decrease >27% (N=41) |
Total (N=88) |
|---|---|---|---|
| Gender: | |||
| Male | 26( 55%) | 28( 68%) | 54( 61%) |
| Female | 21( 45%) | 13 ( 32%) | 34( 39%) |
| Age: | |||
| <60 | 19( 40%) | 21( 51%) | 40( 46%) |
| 60-69 | 16( 34%) | 14(34%) | 30( 34%) |
| >=70 | 12( 26%) | 6 (15%) | 18( 21%) |
| median (min, max) | 61(41,80) | 59(49,81) | 60(41,81) |
| Race: | |||
| White | 38( 81%) | 37( 90%) | 75( 85%) |
| Black or other | 9( 19%) | 4( 10%) | 13( 15%) |
| Histology: | |||
| AdenoCA | 25( 53%) | 19( 46%) | 44( 50%) |
| Squamous | 12( 26%) | 9( 22%) | 21( 24%) |
| Undifferentiated | 10( 21%) | 13( 32%) | 23( 26%) |
| Performance status: | |||
| 0 | 14( 30%) | 13( 32%) | 27( 31%) |
| 1 or 2 | 33( 70%) | 28( 68%) | 61( 69%) |
| Stage | |||
| IIIB | 5( 11%) | 2( 5%) | 7( 8%) |
| IV | 39( 83%) | 37(90%) | 76(86%) |
| Recurrent | 3( 6%) | 2( 5%) | 5( 6%) |